The Defence Research and Development Organisation (DRDO) on Tuesday shared the directions for use of its 2-DG (2-deoxy-D-glucose) drug in coronavirus patients, saying the medicine can be given under the care and prescription of doctors. The approval of the 2-DG drug, which has been developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of the DRDO, has come at a time India has been grappling with a record-breaking wave of coronavirus pandemic that has stretched the country’s healthcare infrastructure to its limit.
Read moreDRDO Shares Directions to Administer 2-DG Drug to Covid Patients. Here's How & When to Use
